Annual Total Liabilities
$39.26 M
-$2.92 M-6.92%
31 December 2023
Summary:
Passage Bio annual total liabilities is currently $39.26 million, with the most recent change of -$2.92 million (-6.92%) on 31 December 2023. During the last 3 years, it has risen by +$2.84 million (+7.81%). PASG annual total liabilities is now -83.28% below its all-time high of $234.87 million, reached on 31 December 2019.PASG Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$39.04 M
+$4.20 M+12.06%
30 September 2024
Summary:
Passage Bio quarterly total liabilities is currently $39.04 million, with the most recent change of +$4.20 million (+12.06%) on 30 September 2024. Over the past year, it has dropped by -$226.00 thousand (-0.58%). PASG quarterly total liabilities is now -83.38% below its all-time high of $234.87 million, reached on 31 December 2019.PASG Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PASG Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -0.6% |
| 3 y3 years | +7.8% | +7.2% |
| 5 y5 years | -83.3% | -83.4% |
PASG Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.9% | +7.8% | -24.8% | +12.1% |
| 5 y | 5 years | -83.3% | +68.6% | -83.4% | +577.6% |
| alltime | all time | -83.3% | +68.6% | -83.4% | +577.6% |
Passage Bio Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $39.04 M(+12.1%) |
| June 2024 | - | $34.84 M(-2.3%) |
| Mar 2024 | - | $35.65 M(-9.2%) |
| Dec 2023 | $39.26 M(-6.9%) | $39.26 M(-8.7%) |
| Sept 2023 | - | $42.98 M(-0.7%) |
| June 2023 | - | $43.28 M(+0.9%) |
| Mar 2023 | - | $42.89 M(+1.7%) |
| Dec 2022 | $42.18 M | $42.18 M(-7.6%) |
| Sept 2022 | - | $45.66 M(-11.1%) |
| June 2022 | - | $51.37 M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $51.91 M(+42.5%) |
| Dec 2021 | $36.42 M(+56.4%) | $36.42 M(+26.8%) |
| Sept 2021 | - | $28.71 M(-22.9%) |
| June 2021 | - | $37.26 M(+57.4%) |
| Mar 2021 | - | $23.67 M(+1.6%) |
| Dec 2020 | $23.29 M(-90.1%) | $23.29 M(+17.7%) |
| Sept 2020 | - | $19.79 M(+34.6%) |
| June 2020 | - | $14.70 M(+155.2%) |
| Mar 2020 | - | $5.76 M(-97.5%) |
| Dec 2019 | $234.87 M(+414.7%) | $234.87 M |
| Dec 2018 | $45.63 M | - |
FAQ
- What is Passage Bio annual total liabilities?
- What is the all time high annual total liabilities for Passage Bio?
- What is Passage Bio quarterly total liabilities?
- What is the all time high quarterly total liabilities for Passage Bio?
- What is Passage Bio quarterly total liabilities year-on-year change?
What is Passage Bio annual total liabilities?
The current annual total liabilities of PASG is $39.26 M
What is the all time high annual total liabilities for Passage Bio?
Passage Bio all-time high annual total liabilities is $234.87 M
What is Passage Bio quarterly total liabilities?
The current quarterly total liabilities of PASG is $39.04 M
What is the all time high quarterly total liabilities for Passage Bio?
Passage Bio all-time high quarterly total liabilities is $234.87 M
What is Passage Bio quarterly total liabilities year-on-year change?
Over the past year, PASG quarterly total liabilities has changed by -$226.00 K (-0.58%)